JP2022540079A5 - - Google Patents
Info
- Publication number
- JP2022540079A5 JP2022540079A5 JP2022500004A JP2022500004A JP2022540079A5 JP 2022540079 A5 JP2022540079 A5 JP 2022540079A5 JP 2022500004 A JP2022500004 A JP 2022500004A JP 2022500004 A JP2022500004 A JP 2022500004A JP 2022540079 A5 JP2022540079 A5 JP 2022540079A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- chain variable
- variable region
- sequence number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025052993A JP2025111457A (ja) | 2019-07-08 | 2025-03-27 | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871565P | 2019-07-08 | 2019-07-08 | |
| US62/871,565 | 2019-07-08 | ||
| PCT/US2020/041228 WO2021007338A1 (en) | 2019-07-08 | 2020-07-08 | Anti-serine protease inhibitor kazal (spik) antibodies, immunoconjugates, and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025052993A Division JP2025111457A (ja) | 2019-07-08 | 2025-03-27 | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022540079A JP2022540079A (ja) | 2022-09-14 |
| JP2022540079A5 true JP2022540079A5 (cg-RX-API-DMAC7.html) | 2023-07-18 |
| JP7658946B2 JP7658946B2 (ja) | 2025-04-08 |
Family
ID=71944318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500004A Active JP7658946B2 (ja) | 2019-07-08 | 2020-07-08 | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
| JP2025052993A Pending JP2025111457A (ja) | 2019-07-08 | 2025-03-27 | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025052993A Pending JP2025111457A (ja) | 2019-07-08 | 2025-03-27 | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12377162B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3996816A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7658946B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN114174341A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3145301A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021007338A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120005029A (zh) | 2018-03-06 | 2025-05-16 | 英凯尔生物科技有限责任公司 | 丝氨酸蛋白酶抑制剂Kazal(SPIK)组合物和方法 |
| JP7658946B2 (ja) | 2019-07-08 | 2025-04-08 | インケア バイオテック, エルエルシー | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
| KR20220080098A (ko) * | 2019-09-11 | 2022-06-14 | 아임케어 바이오테크, 엘엘씨. | 항-세린 프로테아제 억제제 카잘(spik) 항체의 에피토프 |
| US20250369960A1 (en) * | 2022-06-30 | 2025-12-04 | Allonnia, Llc | Per- and polyfluorinated alkyl compound (pfas) binding proteins and uses thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| EP0731106B1 (en) | 1993-10-01 | 2004-11-17 | Teikoku Hormone Mfg. Co., Ltd. | Dolastatin derivatives |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US6248564B1 (en) | 1997-08-29 | 2001-06-19 | Harvard University | Mutant MHC class I molecules |
| US20040018194A1 (en) | 2000-11-28 | 2004-01-29 | Francisco Joseph A. | Recombinant anti-CD30 antibodies and uses thereof |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| US20050123536A1 (en) | 2001-11-20 | 2005-06-09 | Che-Leung Law | Treatment of immunological disorders using anti-dc30 antibodies |
| CA2494104A1 (en) | 2002-07-31 | 2004-04-22 | Seattle Genetics, Inc. | Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| EP1391213A1 (en) | 2002-08-21 | 2004-02-25 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents |
| ES2605443T3 (es) | 2003-11-06 | 2017-03-14 | Seattle Genetics, Inc. | Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| US8193328B2 (en) | 2005-09-08 | 2012-06-05 | Philadelphia Health & Education Corporation | Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents |
| CN101970498A (zh) | 2007-10-25 | 2011-02-09 | 维文蒂阿生物技术公司 | 针对变体HnRNPG的癌相关表位的抗体及其应用 |
| PE20120877A1 (es) | 2009-04-01 | 2012-08-06 | Genentech Inc | ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS |
| US20110206697A1 (en) | 2010-02-19 | 2011-08-25 | The Regents Of The University Of Michigan | Spink1 targeted therapy |
| US20140308657A1 (en) | 2010-12-09 | 2014-10-16 | Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine | Serine protease inhibitor kazal antibodies |
| US9206257B2 (en) | 2011-04-19 | 2015-12-08 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibodies specific for glypican-3 and use thereof |
| CN104994875B (zh) * | 2013-02-15 | 2018-10-09 | 免疫医疗公司 | 嵌合和人源化抗组蛋白抗体 |
| US10746742B2 (en) | 2014-04-25 | 2020-08-18 | Oregon Health & Science University | Methods of viral neutralizing antibody epitope mapping |
| AU2017239637A1 (en) | 2016-03-29 | 2018-11-15 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| EP4219559A3 (en) | 2017-12-22 | 2023-10-18 | Jounce Therapeutics, Inc. | Antibodies for lilrb2 |
| CN120005029A (zh) * | 2018-03-06 | 2025-05-16 | 英凯尔生物科技有限责任公司 | 丝氨酸蛋白酶抑制剂Kazal(SPIK)组合物和方法 |
| CN109678950B (zh) * | 2019-01-08 | 2022-05-10 | 灏灵赛奥(天津)生物科技有限公司 | spink1抗原、能够特异性结合spink1的抗体及其功能片段及其应用和产品 |
| JP7658946B2 (ja) | 2019-07-08 | 2025-04-08 | インケア バイオテック, エルエルシー | カザール型抗セリンプロテアーゼ阻害因子(spik)抗体、免疫複合体、及び使用方法 |
| KR20220080098A (ko) * | 2019-09-11 | 2022-06-14 | 아임케어 바이오테크, 엘엘씨. | 항-세린 프로테아제 억제제 카잘(spik) 항체의 에피토프 |
-
2020
- 2020-07-08 JP JP2022500004A patent/JP7658946B2/ja active Active
- 2020-07-08 CN CN202080054708.9A patent/CN114174341A/zh active Pending
- 2020-07-08 WO PCT/US2020/041228 patent/WO2021007338A1/en not_active Ceased
- 2020-07-08 CA CA3145301A patent/CA3145301A1/en active Pending
- 2020-07-08 US US17/625,693 patent/US12377162B2/en active Active
- 2020-07-08 EP EP20750919.1A patent/EP3996816A1/en active Pending
- 2020-07-08 CN CN202510175468.2A patent/CN119874926A/zh active Pending
-
2025
- 2025-03-27 JP JP2025052993A patent/JP2025111457A/ja active Pending